百洋医药股价上涨4.34% 公司回应欧盟医疗器械禁令影响

金融界
Jul 11, 2025

截至2025年7月10日15时9分,百洋医药股价报21.62元,较前一交易日上涨0.90元,涨幅4.34%。当日成交量为183900手,成交金额达3.98亿元。

百洋医药是一家医药商业企业,业务涉及医药产品批发、零售及供应链服务等领域。公司所属概念板块包括医药商业、山东板块、跨境电商创新药机器人概念等。

根据公开信息,百洋医药证券部相关人士在上市公司交流平台表示,公司涉及单笔超过500万欧元的欧盟政府招标项目极为少见,欧盟近期出台的医疗器械采购禁令对公司业务影响较小。

数据显示,百洋医药当日主力资金净流入1198.29万元,占流通市值的0.11%。

风险提示:投资有风险,入市需谨慎。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10